Cholujová D - Search Results

1

Neurobio-logy of multiple myeloma and its therapeutical use - results of the pilot study with a control arm.

Kotouček P, Enright R, Gregor Sorgerová S, Hunáková Ľ, Chlebcová V, Cholujová D, Jakubíková J, Mravec B, Naništová E, Paneková Ľ, Sedlák J. Kotouček P, et al. Among authors: cholujova d. Klin Onkol. 2023 Winter;37(4):287-299. Klin Onkol. 2023. PMID: 38195383 English.

2

BioBran-augmented maturation of human monocyte-derived dendritic cells.

Cholujova D, Jakubikova J, Sedlak J. Cholujova D, et al. Neoplasma. 2009;56(2):89-95. doi: 10.4149/neo_2009_02_89. Neoplasma. 2009. PMID: 19239320

3

In vitro and ex vivo anti-myeloma effects of nanocomposite As₄S₄/ZnS/Fe₃O₄.

Cholujova D, Koklesova L, Lukacova Bujnakova Z, Dutkova E, Valuskova Z, Beblava P, Matisova A, Sedlak J, Jakubikova J. Cholujova D, et al. Sci Rep. 2022 Oct 26;12(1):17961. doi: 10.1038/s41598-022-22672-5. Sci Rep. 2022. PMID: 36289430 Free PMC article.

4

Exploring the anti-myeloma potential of composite nanoparticles As₄S₄/Fe₃O₄: Insights from in vitro, ex vivo and in vivo studies.

Cholujova D, Bujnakova ZL, Dutkova E, Valuskova Z, Csicsatkova N, Suroviakova K, Marinkovicova ME, Zbellova L, Koklesova L, Sedlak J, Hideshima T, Anderson KC, Jakubikova J. Cholujova D, et al. Nanomedicine. 2024 Nov;62:102777. doi: 10.1016/j.nano.2024.102777. Epub 2024 Aug 5. Nanomedicine. 2024. PMID: 39111377 Free article.

5

Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane.

Hunakova L, Sedlakova O, Cholujova D, Gronesova P, Duraj J, Sedlak J. Hunakova L, et al. Among authors: cholujova d. Neoplasma. 2009;56(6):548-56. doi: 10.4149/neo_2009_06_548. Neoplasma. 2009. PMID: 19728765

6

Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line.

Duraj J, Pastorek M, Vitkovska J, Cholujova D, Gronesova P, Hunakova L, Sedlak J. Duraj J, et al. Among authors: cholujova d. Neoplasma. 2013;60(6):627-34. doi: 10.4149/neo_2013_081. Neoplasma. 2013. PMID: 23906297

7

Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.

Pastorek M, Gronesova P, Cholujova D, Hunakova L, Bujnakova Z, Balaz P, Duraj J, Lee TC, Sedlak J. Pastorek M, et al. Among authors: cholujova d. Neoplasma. 2014;61(6):700-9. doi: 10.4149/neo_2014_085. Neoplasma. 2014. PMID: 25150315

8

Potential biomarkers of exosomal cargo in endocrine signaling.

Zduriencikova M, Gronesova P, Cholujova D, Sedlak J. Zduriencikova M, et al. Among authors: cholujova d. Endocr Regul. 2015 Jul;49(3):141-50. doi: 10.4149/endo_2015_03_141. Endocr Regul. 2015. PMID: 26238497 Review.

9

A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.

Jakubikova J, Cholujova D, Hideshima T, Gronesova P, Soltysova A, Harada T, Joo J, Kong SY, Szalat RE, Richardson PG, Munshi NC, Dorfman DM, Anderson KC. Jakubikova J, et al. Among authors: cholujova d. Oncotarget. 2016 Nov 22;7(47):77326-77341. doi: 10.18632/oncotarget.12643. Oncotarget. 2016. PMID: 27764795 Free PMC article.

10

Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.

Cholujova D, Bujnakova Z, Dutkova E, Hideshima T, Groen RW, Mitsiades CS, Richardson PG, Dorfman DM, Balaz P, Anderson KC, Jakubikova J. Cholujova D, et al. Br J Haematol. 2017 Dec;179(5):756-771. doi: 10.1111/bjh.14974. Epub 2017 Oct 19. Br J Haematol. 2017. PMID: 29048129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters